Threshold Pharmaceuticals, Inc. Is Granted Key U.S. Patents
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD), announced today that the U.S. Patent and Trademark Office has awarded the company key patents relating to two product candidates currently in clinical development.